mTOR inhibition suppresses Myc-driven polyposis by inducing immunogenic cell death

[1]  Tae Kon Kim,et al.  Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities , 2022, Nature Reviews Drug Discovery.

[2]  Jian Yu,et al.  Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer , 2022, Molecular Biomedicine.

[3]  M. Mansour,et al.  Therapeutic targeting of “undruggable” MYC , 2021, EBioMedicine.

[4]  Jian Yu,et al.  Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis , 2021, Oncogene.

[5]  P. Hasty,et al.  Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model. , 2020, Clinical colorectal cancer.

[6]  Jian Yu,et al.  Immunogenic cell death in colon cancer prevention and therapy , 2020, Molecular carcinogenesis.

[7]  J. Taube,et al.  Neoadjuvant checkpoint blockade for cancer immunotherapy , 2020, Science.

[8]  M. Blagosklonny.  Rapamycin for longevity: opinion article , 2019, Aging.

[9]  Z. Ignatova,et al.  ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumor progression , 2019, Nature Cell Biology.

[10]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[11]  Lieping Chen,et al.  A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization , 2018, Cell.

[12]  N. Sonenberg,et al.  Translational Control in Cancer. , 2018, Cold Spring Harbor perspectives in biology.

[13]  K. D. de Visser,et al.  Cancer‐Cell‐Intrinsic Mechanisms Shaping the Tumor Immune Landscape , 2018, Immunity.

[14]  Jian Yu,et al.  Targeting p53-dependent stem cell loss for intestinal chemoprotection , 2018, Science Translational Medicine.

[15]  Jianqun Lu,et al.  Autophagy: novel applications of nonsteroidal anti‐inflammatory drugs for primary cancer , 2017, Cancer medicine.

[16]  K. Shokat,et al.  Drugging the 'undruggable' cancer targets , 2017, Nature Reviews Cancer.

[17]  Xing-hua Chen,et al.  Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma , 2017, PeerJ.

[18]  L. Zitvogel,et al.  Immunogenic cell death in cancer and infectious disease , 2016, Nature Reviews Immunology.

[19]  Jian Yu,et al.  BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells , 2016, Oncotarget.

[20]  Jian Yu,et al.  mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction upon 4E-BP1 dephosphorylation , 2015, Oncogene.

[21]  C. Dang.  A Time for MYC: Metabolism and Therapy. , 2016, Cold Spring Harbor symposia on quantitative biology.

[22]  Claudia Knothe,et al.  AMP-activated protein kinase is activated by non-steroidal anti-inflammatory drugs. , 2015, European journal of pharmacology.

[23]  C. Koumenis,et al.  Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy. , 2015, Seminars in cancer biology.

[24]  L. Galluzzi,et al.  eIF2α phosphorylation as a biomarker of immunogenic cell death. , 2015, Seminars in cancer biology.

[25]  Michael N. Hall,et al.  mTORC1 mediated translational elongation limits intestinal tumour initiation and growth , 2014, Nature.

[26]  Jian Yu,et al.  BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs , 2014, Proceedings of the National Academy of Sciences.

[27]  E. Fearon,et al.  Rapamycin Inhibition of Polyposis and Progression to Dysplasia in a Mouse Model , 2014, PloS one.

[28]  R. Eisenman,et al.  Stress-induced cleavage of Myc promotes cancer cell survival , 2014, Genes & development.

[29]  Jian Yu,et al.  Role of Apoptosis in Colon Cancer Biology, Therapy, and Prevention , 2013, Current Colorectal Cancer Reports.

[30]  K. Shokat,et al.  Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers , 2013, Proceedings of the National Academy of Sciences.

[31]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[32]  C. Eng,et al.  The promise of mTOR inhibitors in the treatment of colorectal cancer , 2012, Expert opinion on investigational drugs.

[33]  O. Finn,et al.  Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[35]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[36]  D. Ron,et al.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress , 2011, Nature Cell Biology.

[37]  Jian Yu,et al.  Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis , 2010, Proceedings of the National Academy of Sciences.

[38]  P. Pandolfi,et al.  eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression , 2010, Proceedings of the National Academy of Sciences.

[39]  Jongdae Lee,et al.  ERK activation drives intestinal tumorigenesis in Apcmin/+ mice , 2010, Nature Medicine.

[40]  Jian Yu,et al.  Mitochondrial signaling in cell death via the Bcl-2 family , 2010, Cancer biology & therapy.

[41]  H. Lane,et al.  Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice , 2008, Proceedings of the National Academy of Sciences.

[42]  Julie A. Wilkins,et al.  Myc deletion rescues Apc deficiency in the small intestine , 2007, Nature.

[43]  L. Helman,et al.  Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism , 2007, Oncogene.

[44]  Leroy Hood,et al.  PTEN-deficient intestinal stem cells initiate intestinal polyposis , 2007, Nature Genetics.

[45]  D. Besselsen,et al.  Role of c-Myc in intestinal tumorigenesis of the Apc min/+ mouse1 , 2006, Cancer biology & therapy.

[46]  S. Korsmeyer,et al.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.